nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—FMO3—Vandetanib—thyroid cancer	0.407	0.691	CbGbCtD
Dapsone—PTGS2—thyroid cancer	0.335	1	CbGaD
Dapsone—CYP3A7—Sorafenib—thyroid cancer	0.0328	0.0558	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0328	0.0558	CbGbCtD
Dapsone—CYP3A5—Sorafenib—thyroid cancer	0.0246	0.0419	CbGbCtD
Dapsone—CYP2C8—Sorafenib—thyroid cancer	0.0237	0.0402	CbGbCtD
Dapsone—CYP2C19—Sorafenib—thyroid cancer	0.0199	0.0338	CbGbCtD
Dapsone—CYP2C9—Sorafenib—thyroid cancer	0.0165	0.0281	CbGbCtD
Dapsone—CYP3A4—Vandetanib—thyroid cancer	0.0159	0.0271	CbGbCtD
Dapsone—CYP3A4—Sorafenib—thyroid cancer	0.00961	0.0163	CbGbCtD
Dapsone—Hypoalbuminaemia—Sorafenib—thyroid cancer	0.00595	0.134	CcSEcCtD
Dapsone—CYP3A4—Doxorubicin—thyroid cancer	0.00583	0.0099	CbGbCtD
Dapsone—Nephrotic syndrome—Sorafenib—thyroid cancer	0.00269	0.0605	CcSEcCtD
Dapsone—Proteinuria—Vandetanib—thyroid cancer	0.00219	0.0494	CcSEcCtD
Dapsone—Protein urine present—Vandetanib—thyroid cancer	0.00216	0.0487	CcSEcCtD
Dapsone—Proteinuria—Sorafenib—thyroid cancer	0.00148	0.0333	CcSEcCtD
Dapsone—Protein urine present—Sorafenib—thyroid cancer	0.00146	0.0328	CcSEcCtD
Dapsone—Nasopharyngitis—Vandetanib—thyroid cancer	0.00125	0.0282	CcSEcCtD
Dapsone—Skin exfoliation—Sorafenib—thyroid cancer	0.00124	0.0279	CcSEcCtD
Dapsone—Influenza—Vandetanib—thyroid cancer	0.00121	0.0272	CcSEcCtD
Dapsone—Pancreatitis—Vandetanib—thyroid cancer	0.00118	0.0267	CcSEcCtD
Dapsone—Photosensitivity reaction—Vandetanib—thyroid cancer	0.0011	0.0248	CcSEcCtD
Dapsone—Sinusitis—Vandetanib—thyroid cancer	0.00101	0.0228	CcSEcCtD
Dapsone—Nasopharyngitis—Sorafenib—thyroid cancer	0.000843	0.019	CcSEcCtD
Dapsone—Pancreatitis—Sorafenib—thyroid cancer	0.000799	0.018	CcSEcCtD
Dapsone—Vision blurred—Vandetanib—thyroid cancer	0.000793	0.0179	CcSEcCtD
Dapsone—Cough—Vandetanib—thyroid cancer	0.000735	0.0165	CcSEcCtD
Dapsone—Neuropathy peripheral—Sorafenib—thyroid cancer	0.000712	0.016	CcSEcCtD
Dapsone—Albuminuria—Epirubicin—thyroid cancer	0.000643	0.0145	CcSEcCtD
Dapsone—Insomnia—Vandetanib—thyroid cancer	0.000621	0.014	CcSEcCtD
Dapsone—Tinnitus—Sorafenib—thyroid cancer	0.000608	0.0137	CcSEcCtD
Dapsone—Albuminuria—Doxorubicin—thyroid cancer	0.000595	0.0134	CcSEcCtD
Dapsone—Erythema—Sorafenib—thyroid cancer	0.000568	0.0128	CcSEcCtD
Dapsone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000562	0.0127	CcSEcCtD
Dapsone—Abdominal pain—Vandetanib—thyroid cancer	0.000543	0.0122	CcSEcCtD
Dapsone—Body temperature increased—Vandetanib—thyroid cancer	0.000543	0.0122	CcSEcCtD
Dapsone—Cough—Sorafenib—thyroid cancer	0.000496	0.0112	CcSEcCtD
Dapsone—Skin exfoliation—Epirubicin—thyroid cancer	0.000458	0.0103	CcSEcCtD
Dapsone—Vomiting—Vandetanib—thyroid cancer	0.000437	0.00984	CcSEcCtD
Dapsone—Headache—Vandetanib—thyroid cancer	0.00043	0.00969	CcSEcCtD
Dapsone—Skin exfoliation—Doxorubicin—thyroid cancer	0.000424	0.00955	CcSEcCtD
Dapsone—Nausea—Vandetanib—thyroid cancer	0.000408	0.00919	CcSEcCtD
Dapsone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000379	0.00854	CcSEcCtD
Dapsone—Abdominal pain—Sorafenib—thyroid cancer	0.000366	0.00825	CcSEcCtD
Dapsone—Body temperature increased—Sorafenib—thyroid cancer	0.000366	0.00825	CcSEcCtD
Dapsone—Nasopharyngitis—Epirubicin—thyroid cancer	0.000312	0.00702	CcSEcCtD
Dapsone—Muscular weakness—Epirubicin—thyroid cancer	0.000307	0.00692	CcSEcCtD
Dapsone—Influenza—Epirubicin—thyroid cancer	0.000301	0.00678	CcSEcCtD
Dapsone—Pancreatitis—Epirubicin—thyroid cancer	0.000295	0.00665	CcSEcCtD
Dapsone—Vomiting—Sorafenib—thyroid cancer	0.000295	0.00664	CcSEcCtD
Dapsone—Headache—Sorafenib—thyroid cancer	0.00029	0.00654	CcSEcCtD
Dapsone—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000288	0.00649	CcSEcCtD
Dapsone—Muscular weakness—Doxorubicin—thyroid cancer	0.000284	0.00641	CcSEcCtD
Dapsone—Influenza—Doxorubicin—thyroid cancer	0.000279	0.00628	CcSEcCtD
Dapsone—Nausea—Sorafenib—thyroid cancer	0.000275	0.0062	CcSEcCtD
Dapsone—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000275	0.00619	CcSEcCtD
Dapsone—Pancreatitis—Doxorubicin—thyroid cancer	0.000273	0.00615	CcSEcCtD
Dapsone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000263	0.00593	CcSEcCtD
Dapsone—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000254	0.00573	CcSEcCtD
Dapsone—Sinusitis—Epirubicin—thyroid cancer	0.000252	0.00568	CcSEcCtD
Dapsone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000244	0.00549	CcSEcCtD
Dapsone—Pharyngitis—Epirubicin—thyroid cancer	0.000239	0.00539	CcSEcCtD
Dapsone—Sinusitis—Doxorubicin—thyroid cancer	0.000233	0.00525	CcSEcCtD
Dapsone—Tinnitus—Epirubicin—thyroid cancer	0.000225	0.00506	CcSEcCtD
Dapsone—Pharyngitis—Doxorubicin—thyroid cancer	0.000221	0.00499	CcSEcCtD
Dapsone—Erythema—Epirubicin—thyroid cancer	0.00021	0.00473	CcSEcCtD
Dapsone—Tinnitus—Doxorubicin—thyroid cancer	0.000208	0.00468	CcSEcCtD
Dapsone—Vision blurred—Epirubicin—thyroid cancer	0.000198	0.00446	CcSEcCtD
Dapsone—Erythema—Doxorubicin—thyroid cancer	0.000194	0.00437	CcSEcCtD
Dapsone—Vertigo—Epirubicin—thyroid cancer	0.000189	0.00425	CcSEcCtD
Dapsone—NAT2—Metabolism—NDUFA13—thyroid cancer	0.000185	0.00579	CbGpPWpGaD
Dapsone—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	0.000184	0.00575	CbGpPWpGaD
Dapsone—Cough—Epirubicin—thyroid cancer	0.000183	0.00413	CcSEcCtD
Dapsone—Vision blurred—Doxorubicin—thyroid cancer	0.000183	0.00412	CcSEcCtD
Dapsone—MPO—C-MYB transcription factor network—PTGS2—thyroid cancer	0.000181	0.00566	CbGpPWpGaD
Dapsone—MPO—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000175	0.00545	CbGpPWpGaD
Dapsone—Vertigo—Doxorubicin—thyroid cancer	0.000174	0.00393	CcSEcCtD
Dapsone—NAT2—Metabolism—CHST14—thyroid cancer	0.000174	0.00544	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000172	0.00538	CbGpPWpGaD
Dapsone—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00017	0.00531	CbGpPWpGaD
Dapsone—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00017	0.00531	CbGpPWpGaD
Dapsone—Cough—Doxorubicin—thyroid cancer	0.000169	0.00382	CcSEcCtD
Dapsone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.000169	0.00528	CbGpPWpGaD
Dapsone—Tachycardia—Epirubicin—thyroid cancer	0.000167	0.00377	CcSEcCtD
Dapsone—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000164	0.00513	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—CCND1—thyroid cancer	0.000164	0.00512	CbGpPWpGaD
Dapsone—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000163	0.00511	CbGpPWpGaD
Dapsone—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000158	0.00495	CbGpPWpGaD
Dapsone—FMO3—Metabolism—MINPP1—thyroid cancer	0.000158	0.00492	CbGpPWpGaD
Dapsone—Insomnia—Epirubicin—thyroid cancer	0.000155	0.00349	CcSEcCtD
Dapsone—Tachycardia—Doxorubicin—thyroid cancer	0.000155	0.00348	CcSEcCtD
Dapsone—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.00015	0.00468	CbGpPWpGaD
Dapsone—CYP2E1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000146	0.00456	CbGpPWpGaD
Dapsone—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000146	0.00455	CbGpPWpGaD
Dapsone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000145	0.00454	CbGpPWpGaD
Dapsone—Insomnia—Doxorubicin—thyroid cancer	0.000143	0.00323	CcSEcCtD
Dapsone—PTGS2—Spinal Cord Injury—LGALS3—thyroid cancer	0.000142	0.00445	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—NRAS—thyroid cancer	0.000141	0.0044	CbGpPWpGaD
Dapsone—NAT2—Metabolism—HPGD—thyroid cancer	0.00014	0.00439	CbGpPWpGaD
Dapsone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00014	0.00315	CcSEcCtD
Dapsone—Abdominal pain—Epirubicin—thyroid cancer	0.000135	0.00305	CcSEcCtD
Dapsone—Body temperature increased—Epirubicin—thyroid cancer	0.000135	0.00305	CcSEcCtD
Dapsone—FMO3—Metabolism—NDUFA13—thyroid cancer	0.000134	0.00419	CbGpPWpGaD
Dapsone—MPO—Folate Metabolism—TP53—thyroid cancer	0.000131	0.00409	CbGpPWpGaD
Dapsone—CYP2C18—Biological oxidations—RXRA—thyroid cancer	0.000131	0.00408	CbGpPWpGaD
Dapsone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00013	0.00292	CcSEcCtD
Dapsone—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000126	0.00394	CbGpPWpGaD
Dapsone—FMO3—Metabolism—CHST14—thyroid cancer	0.000126	0.00394	CbGpPWpGaD
Dapsone—Body temperature increased—Doxorubicin—thyroid cancer	0.000125	0.00282	CcSEcCtD
Dapsone—Abdominal pain—Doxorubicin—thyroid cancer	0.000125	0.00282	CcSEcCtD
Dapsone—MPO—C-MYB transcription factor network—KRAS—thyroid cancer	0.000121	0.00379	CbGpPWpGaD
Dapsone—CYP2E1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000118	0.0037	CbGpPWpGaD
Dapsone—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000118	0.00369	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—thyroid cancer	0.000113	0.00354	CbGpPWpGaD
Dapsone—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000113	0.00352	CbGpPWpGaD
Dapsone—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000112	0.00351	CbGpPWpGaD
Dapsone—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000112	0.0035	CbGpPWpGaD
Dapsone—Vomiting—Epirubicin—thyroid cancer	0.000109	0.00245	CcSEcCtD
Dapsone—Headache—Epirubicin—thyroid cancer	0.000107	0.00242	CcSEcCtD
Dapsone—MPO—C-MYB transcription factor network—HRAS—thyroid cancer	0.000103	0.00322	CbGpPWpGaD
Dapsone—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000103	0.00321	CbGpPWpGaD
Dapsone—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000102	0.0032	CbGpPWpGaD
Dapsone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000102	0.00319	CbGpPWpGaD
Dapsone—Nausea—Epirubicin—thyroid cancer	0.000102	0.00229	CcSEcCtD
Dapsone—FMO3—Metabolism—HPGD—thyroid cancer	0.000102	0.00317	CbGpPWpGaD
Dapsone—Vomiting—Doxorubicin—thyroid cancer	0.000101	0.00227	CcSEcCtD
Dapsone—Headache—Doxorubicin—thyroid cancer	9.93e-05	0.00224	CcSEcCtD
Dapsone—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	9.88e-05	0.00309	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—CDK1—thyroid cancer	9.73e-05	0.00304	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—MINPP1—thyroid cancer	9.6e-05	0.003	CbGpPWpGaD
Dapsone—Nausea—Doxorubicin—thyroid cancer	9.41e-05	0.00212	CcSEcCtD
Dapsone—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	9.14e-05	0.00285	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.95e-05	0.00279	CbGpPWpGaD
Dapsone—CYP3A7—Biological oxidations—RXRA—thyroid cancer	8.68e-05	0.00271	CbGpPWpGaD
Dapsone—PTGS1—Biological oxidations—RXRA—thyroid cancer	8.42e-05	0.00263	CbGpPWpGaD
Dapsone—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	8.33e-05	0.0026	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—NDUFA13—thyroid cancer	8.16e-05	0.00255	CbGpPWpGaD
Dapsone—NAT2—Metabolism—TPR—thyroid cancer	8.07e-05	0.00252	CbGpPWpGaD
Dapsone—NAT2—Metabolism—PRKAR1A—thyroid cancer	7.94e-05	0.00248	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—CHST14—thyroid cancer	7.67e-05	0.0024	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	7.42e-05	0.00232	CbGpPWpGaD
Dapsone—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.26e-05	0.00227	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	7.15e-05	0.00223	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.1e-05	0.00222	CbGpPWpGaD
Dapsone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	7.06e-05	0.00221	CbGpPWpGaD
Dapsone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	6.78e-05	0.00212	CbGpPWpGaD
Dapsone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	6.74e-05	0.00211	CbGpPWpGaD
Dapsone—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	6.48e-05	0.00202	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	6.38e-05	0.00199	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—MINPP1—thyroid cancer	6.38e-05	0.00199	CbGpPWpGaD
Dapsone—CYP2E1—Biological oxidations—RXRA—thyroid cancer	6.29e-05	0.00196	CbGpPWpGaD
Dapsone—CYP3A5—Biological oxidations—RXRA—thyroid cancer	6.28e-05	0.00196	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—MINPP1—thyroid cancer	6.18e-05	0.00193	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—HPGD—thyroid cancer	6.18e-05	0.00193	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	6.14e-05	0.00192	CbGpPWpGaD
Dapsone—NAT2—Metabolism—SLC5A5—thyroid cancer	6.04e-05	0.00189	CbGpPWpGaD
Dapsone—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	5.91e-05	0.00184	CbGpPWpGaD
Dapsone—FMO3—Metabolism—TPR—thyroid cancer	5.83e-05	0.00182	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.78e-05	0.00181	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PRKAR1A—thyroid cancer	5.74e-05	0.00179	CbGpPWpGaD
Dapsone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	5.49e-05	0.00172	CbGpPWpGaD
Dapsone—CYP2C8—Biological oxidations—RXRA—thyroid cancer	5.44e-05	0.0017	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	5.43e-05	0.00169	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—NDUFA13—thyroid cancer	5.42e-05	0.00169	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	5.32e-05	0.00166	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—NDUFA13—thyroid cancer	5.26e-05	0.00164	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.16e-05	0.00161	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CHST14—thyroid cancer	5.1e-05	0.00159	CbGpPWpGaD
Dapsone—NAT2—Metabolism—RXRA—thyroid cancer	5.07e-05	0.00159	CbGpPWpGaD
Dapsone—PTGS2—Disease—TRIM24—thyroid cancer	4.98e-05	0.00156	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—CHST14—thyroid cancer	4.94e-05	0.00154	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—MINPP1—thyroid cancer	4.91e-05	0.00153	CbGpPWpGaD
Dapsone—CYP2C19—Biological oxidations—RXRA—thyroid cancer	4.85e-05	0.00152	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.7e-05	0.00147	CbGpPWpGaD
Dapsone—PTGS2—Disease—CHST14—thyroid cancer	4.69e-05	0.00146	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—MINPP1—thyroid cancer	4.62e-05	0.00144	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—MINPP1—thyroid cancer	4.61e-05	0.00144	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	4.58e-05	0.00143	CbGpPWpGaD
Dapsone—PTGS2—Disease—TRIM33—thyroid cancer	4.44e-05	0.00139	CbGpPWpGaD
Dapsone—CYP2C9—Biological oxidations—RXRA—thyroid cancer	4.42e-05	0.00138	CbGpPWpGaD
Dapsone—FMO3—Metabolism—SLC5A5—thyroid cancer	4.37e-05	0.00136	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—NDUFA13—thyroid cancer	4.17e-05	0.0013	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—HPGD—thyroid cancer	4.11e-05	0.00128	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	4.05e-05	0.00127	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—MINPP1—thyroid cancer	3.99e-05	0.00125	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—HPGD—thyroid cancer	3.98e-05	0.00124	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	3.94e-05	0.00123	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—NDUFA13—thyroid cancer	3.93e-05	0.00123	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CHST14—thyroid cancer	3.92e-05	0.00123	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—NDUFA13—thyroid cancer	3.92e-05	0.00122	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CHST14—thyroid cancer	3.69e-05	0.00115	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CHST14—thyroid cancer	3.69e-05	0.00115	CbGpPWpGaD
Dapsone—FMO3—Metabolism—RXRA—thyroid cancer	3.67e-05	0.00115	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—MINPP1—thyroid cancer	3.57e-05	0.00111	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—TPR—thyroid cancer	3.55e-05	0.00111	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PRKAR1A—thyroid cancer	3.49e-05	0.00109	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—NDUFA13—thyroid cancer	3.4e-05	0.00106	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	3.35e-05	0.00105	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.25e-05	0.00102	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.23e-05	0.00101	CbGpPWpGaD
Dapsone—NAT2—Metabolism—PPARG—thyroid cancer	3.2e-05	0.001	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CHST14—thyroid cancer	3.19e-05	0.000997	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—HPGD—thyroid cancer	3.16e-05	0.000988	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—NDUFA13—thyroid cancer	3.03e-05	0.000947	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—HPGD—thyroid cancer	2.98e-05	0.00093	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—HPGD—thyroid cancer	2.97e-05	0.000928	CbGpPWpGaD
Dapsone—PTGS2—Disease—TCF7L1—thyroid cancer	2.96e-05	0.000926	CbGpPWpGaD
Dapsone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.92e-05	0.000912	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CHST14—thyroid cancer	2.85e-05	0.00089	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—NDUFA13—thyroid cancer	2.76e-05	0.000863	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.76e-05	0.000861	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	2.67e-05	0.000834	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.66e-05	0.000831	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—SLC5A5—thyroid cancer	2.66e-05	0.000831	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CHST14—thyroid cancer	2.6e-05	0.000812	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—HPGD—thyroid cancer	2.57e-05	0.000804	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.57e-05	0.000802	CbGpPWpGaD
Dapsone—NAT2—Metabolism—PTGS2—thyroid cancer	2.52e-05	0.000787	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—TPR—thyroid cancer	2.36e-05	0.000738	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	2.32e-05	0.000726	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PPARG—thyroid cancer	2.32e-05	0.000724	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—HPGD—thyroid cancer	2.3e-05	0.000718	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—TPR—thyroid cancer	2.29e-05	0.000715	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PRKAR1A—thyroid cancer	2.25e-05	0.000703	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—RXRA—thyroid cancer	2.23e-05	0.000698	CbGpPWpGaD
Dapsone—NAT2—Metabolism—PTEN—thyroid cancer	2.2e-05	0.000687	CbGpPWpGaD
Dapsone—PTGS2—Disease—TPR—thyroid cancer	2.17e-05	0.000678	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.14e-05	0.00067	CbGpPWpGaD
Dapsone—PTGS2—Disease—PRKAR1A—thyroid cancer	2.13e-05	0.000667	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—HPGD—thyroid cancer	2.09e-05	0.000654	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.09e-05	0.000652	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.04e-05	0.000638	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.04e-05	0.000637	CbGpPWpGaD
Dapsone—PTGS2—Disease—MEN1—thyroid cancer	2.04e-05	0.000637	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.86e-05	0.000582	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.82e-05	0.000569	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PTGS2—thyroid cancer	1.82e-05	0.000569	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—TPR—thyroid cancer	1.82e-05	0.000568	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.82e-05	0.000567	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PRKAR1A—thyroid cancer	1.79e-05	0.000558	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.77e-05	0.000552	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CHST14—thyroid cancer	1.71e-05	0.000535	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—SLC5A5—thyroid cancer	1.71e-05	0.000535	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—TPR—thyroid cancer	1.71e-05	0.000534	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—TPR—thyroid cancer	1.71e-05	0.000533	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.7e-05	0.000531	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	1.68e-05	0.000526	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.68e-05	0.000525	CbGpPWpGaD
Dapsone—PTGS2—Disease—CALCA—thyroid cancer	1.62e-05	0.000507	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.62e-05	0.000506	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.61e-05	0.000501	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PTEN—thyroid cancer	1.59e-05	0.000496	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.53e-05	0.000479	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—RXRA—thyroid cancer	1.49e-05	0.000464	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—TPR—thyroid cancer	1.48e-05	0.000462	CbGpPWpGaD
Dapsone—PTGS2—Disease—CDK1—thyroid cancer	1.47e-05	0.000459	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.45e-05	0.000454	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—RXRA—thyroid cancer	1.44e-05	0.00045	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PPARG—thyroid cancer	1.41e-05	0.000441	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.4e-05	0.000437	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—HPGD—thyroid cancer	1.38e-05	0.000432	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—SLC5A5—thyroid cancer	1.36e-05	0.000425	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—TPR—thyroid cancer	1.32e-05	0.000412	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.32e-05	0.000412	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.3e-05	0.000406	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—SLC5A5—thyroid cancer	1.28e-05	0.0004	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.28e-05	0.000399	CbGpPWpGaD
Dapsone—NAT2—Metabolism—AKT1—thyroid cancer	1.27e-05	0.000396	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—TPR—thyroid cancer	1.2e-05	0.000376	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.18e-05	0.00037	CbGpPWpGaD
Dapsone—PTGS2—Disease—NRG1—thyroid cancer	1.18e-05	0.000369	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.18e-05	0.000368	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—RXRA—thyroid cancer	1.14e-05	0.000357	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.11e-05	0.000347	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PTGS2—thyroid cancer	1.11e-05	0.000347	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.11e-05	0.000346	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—RXRA—thyroid cancer	1.08e-05	0.000336	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—RXRA—thyroid cancer	1.07e-05	0.000335	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.07e-05	0.000335	CbGpPWpGaD
Dapsone—PTGS2—Disease—TERT—thyroid cancer	1.06e-05	0.000331	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.04e-05	0.000324	CbGpPWpGaD
Dapsone—PTGS2—Disease—HIF1A—thyroid cancer	1.01e-05	0.000316	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—SLC5A5—thyroid cancer	9.88e-06	0.000309	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PTEN—thyroid cancer	9.68e-06	0.000302	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PPARG—thyroid cancer	9.38e-06	0.000293	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—RXRA—thyroid cancer	9.3e-06	0.00029	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.26e-06	0.000289	CbGpPWpGaD
Dapsone—FMO3—Metabolism—AKT1—thyroid cancer	9.16e-06	0.000286	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PPARG—thyroid cancer	9.09e-06	0.000284	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.04e-06	0.000282	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—SLC5A5—thyroid cancer	9.01e-06	0.000281	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.44e-06	0.000264	CbGpPWpGaD
Dapsone—PTGS2—Disease—BRAF—thyroid cancer	8.39e-06	0.000262	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—RXRA—thyroid cancer	8.3e-06	0.000259	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.07e-06	0.000252	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—TPR—thyroid cancer	7.93e-06	0.000248	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	7.81e-06	0.000244	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—RXRA—thyroid cancer	7.57e-06	0.000236	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PTGS2—thyroid cancer	7.38e-06	0.00023	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.36e-06	0.00023	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PPARG—thyroid cancer	7.21e-06	0.000225	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PTGS2—thyroid cancer	7.15e-06	0.000223	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PPARG—thyroid cancer	6.79e-06	0.000212	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PPARG—thyroid cancer	6.78e-06	0.000212	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PTEN—thyroid cancer	6.43e-06	0.000201	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PTEN—thyroid cancer	6.24e-06	0.000195	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	5.94e-06	0.000186	CbGpPWpGaD
Dapsone—PTGS2—Disease—PTEN—thyroid cancer	5.91e-06	0.000185	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PPARG—thyroid cancer	5.87e-06	0.000183	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—AKT1—thyroid cancer	5.58e-06	0.000174	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PTGS2—thyroid cancer	5.34e-06	0.000167	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PTGS2—thyroid cancer	5.33e-06	0.000167	CbGpPWpGaD
Dapsone—PTGS2—Disease—NRAS—thyroid cancer	5.27e-06	0.000165	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PPARG—thyroid cancer	5.24e-06	0.000164	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—RXRA—thyroid cancer	4.99e-06	0.000156	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PTEN—thyroid cancer	4.95e-06	0.000155	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PPARG—thyroid cancer	4.78e-06	0.000149	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PTEN—thyroid cancer	4.66e-06	0.000146	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PTEN—thyroid cancer	4.65e-06	0.000145	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PTGS2—thyroid cancer	4.62e-06	0.000144	CbGpPWpGaD
Dapsone—PTGS2—Disease—KRAS—thyroid cancer	4.54e-06	0.000142	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PTGS2—thyroid cancer	4.12e-06	0.000129	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PTEN—thyroid cancer	4.03e-06	0.000126	CbGpPWpGaD
Dapsone—PTGS2—Disease—HRAS—thyroid cancer	3.86e-06	0.000121	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PTGS2—thyroid cancer	3.76e-06	0.000117	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—AKT1—thyroid cancer	3.71e-06	0.000116	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PTEN—thyroid cancer	3.59e-06	0.000112	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—AKT1—thyroid cancer	3.59e-06	0.000112	CbGpPWpGaD
Dapsone—PTGS2—Disease—AKT1—thyroid cancer	3.41e-06	0.000106	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PTEN—thyroid cancer	3.28e-06	0.000102	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PPARG—thyroid cancer	3.15e-06	9.84e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—AKT1—thyroid cancer	2.85e-06	8.91e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—AKT1—thyroid cancer	2.69e-06	8.39e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—AKT1—thyroid cancer	2.68e-06	8.37e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.48e-06	7.74e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—AKT1—thyroid cancer	2.32e-06	7.25e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PTEN—thyroid cancer	2.16e-06	6.75e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—AKT1—thyroid cancer	2.07e-06	6.47e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—AKT1—thyroid cancer	1.89e-06	5.9e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—AKT1—thyroid cancer	1.25e-06	3.89e-05	CbGpPWpGaD
